Finance

Lists
VTVT:NASDAQ
vTv Therapeutics Inc
$30.46
-3.12%
(-0.98) 1D
$30.46
0.00% (0.00)
After hours
Closed: Sep 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTVT...
Open
$31.30
High
$31.90
Low
$29.76
Mkt. cap
120.44M
Avg. vol.
66.26K
Volume
45.33K
52-wk high
$44.00
52-wk low
$18.97
EPS
-$1.06
Beta
0.31
Shares outstanding
3.95M
No. of employees
26
Open
$31.30
High
$31.90
Low
$29.76
Mkt. cap
120.44M
Avg. vol.
66.26K
Volume
45.33K
52-wk high
$44.00
52-wk low
$18.97
EPS
-$1.06
Beta
0.31
Shares outstanding
3.95M
No. of employees
26
News stories
From web sources and news partners
About vTv Therapeutics Inc
CEO-
Employees26
Founded2015
HeadquartersHigh Point, North Carolina, United States
SectorBiotechnology
Websitevtvtherapeutics.com
Analyst ratings
Based on 6 analysts giving stock ratings to VTVT in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for VTVT in the last 3 months.
Highest
Current $30.46
$67.00 (+119.96%)
Average
$58.50 (+92.06%)
Lowest
$42.00 (+37.89%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Dolezal
LifeSci Capital
Buy
Initiated
$60.00
+97%
09/02/2026
Adam Walsh
Roth MKM
Buy
Reiterated
$58.00
+90.4%
08/07/2026
Kambiz Yazdi
BTIG
Buy
Maintained
$57.00
+87.1%
08/06/2026
Ritu Baral
TD Cowen
Buy
Maintained
$67.00
+120%
08/07/2026
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
$42.00
+37.9%
08/07/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$67.00
+120%
06/30/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$55.00
+80.6%
05/14/2026
Michael DiFiore
Evercore ISI
Buy
Initiated
$44.00
+44.5%
03/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
36.84M
-
Cost of goods sold
7.02M
3.91M
8.98M
8.77M
Cost of revenue
7.02M
3.91M
8.98M
8.77M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.68M
3.98M
4.60M
5.16M
Operating expense
3.68M
3.98M
4.60M
5.16M
Total operating expenses
10.70M
7.88M
13.58M
13.93M
Operating income
-10.70M
-7.88M
23.26M
-13.93M
Other non operating income
-40.00K
-117.00K
33.00K
64.00K
EBT including unusual items
-10.34M
-7.14M
24.13M
-13.05M
EBT excluding unusual items
-10.34M
-7.14M
24.13M
-13.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.70M
-7.14M
24.13M
-13.05M
Net profit margin
-
-
65.51%
-
Earnings per share
-1.08
-0.58
1.65
-1.05
Interest and investment income
399.00K
865.00K
838.00K
812.00K
Interest expense
-5.00K
-1.00K
-
-
Net interest expenses
394.00K
864.00K
838.00K
812.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.70M
-7.88M
23.26M
-13.93M
Gain or loss from assets sale
-
6.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps